VANGUARD GROUP INC - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 45 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,398,913
-25.6%
6,095,675
-0.1%
0.00%
Q2 2023$15,312,231
+497.2%
6,100,490
+316.4%
0.00%
Q1 2023$2,563,976
-58.2%
1,465,129
+1.5%
0.00%
Q4 2022$6,135,121
+564.7%
1,443,558
+86.0%
0.00%
Q3 2022$923,000
+18.9%
775,9220.0%0.00%
Q2 2022$776,000
-65.2%
775,922
-14.9%
0.00%
Q1 2022$2,233,000
-8.5%
911,396
+0.5%
0.00%
Q4 2021$2,440,000
-46.2%
906,887
+0.1%
0.00%
Q3 2021$4,537,000
-30.9%
905,530
+2.9%
0.00%
Q2 2021$6,564,000
+103.5%
879,898
+60.1%
0.00%
Q1 2021$3,226,000
+24.9%
549,5420.0%0.00%
Q4 2020$2,583,000549,5420.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Alpine Global Management, LLC 202,928$8620.29%
AWM Investment Company, Inc. 300,000$1,275,0000.18%
Virtus ETF Advisers LLC 42,835$182,0490.10%
Baker Brothers Advisors 2,000,000$8,500,0000.05%
VANCE WEALTH, INC. 13,299$56,5210.04%
Inscription Capital, LLC 17,000$72,2500.02%
Steward Partners Investment Advisory, LLC 305,000$1,296,2500.02%
BOOTHBAY FUND MANAGEMENT, LLC 221,205$940,1210.02%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$166,4980.02%
683 Capital Management, LLC 50,838$216,0620.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders